>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS
>

FDA MEDWATCH ALERTS

RSS

January 12, 2012

Respironics, Inc. Trilogy 100 Ventilators: Class I Recall - Device May Stop Delivering Therapy to Patient

Summary:

FDA notified health care professionals of the Class 1 recall of this product due to a manufacturing issue can stop delivering therapy to the patient. Part of the blower that circulates air and other gases through the ventilator may move out of position and cause the device to alarm.  Failure to respond could result in the potential for harm or death of a ventilator-dependent patient.

January 12, 2012

Bedford Laboratories Vecuronium Bromide And Polymyxin B For Injection USP For Injection: Recall - Glass Particles

Summary:

Bedford Laboratories issued guidance on the nationwide voluntary product recalls originally issued on August 2, 2011. The recalls were initiated after the discovery of a visible glass particle in a limited number of vials within the lots listed.

January 09, 2012

Endo Pharmaceuticals Opiate Products by Novartis Consumer Health: Public Health Advisory - Potential Safety Risk

Summary:

FDA is advising health care professionals and patients of a potential problem with opiate products manufactured and packaged for Endo Pharmaceuticals by Novartis Consumer Health at its Lincoln, Nebraska manufacturing site.

>

ASA FEATURED PRODUCT

Self-Education and Evaluation (SEE) Program

SKU: 30701-12CE

... Read more »

Single Copies, Member Price: $300

The Wall Street Journal Reports Teva Will Stop Making Propofol

Teva Will Stop Making Anesthetic

Chicago — (March 30, 2010) 

Teva Pharmaceutical Industries Ltd. has told federal regulators that it will stop making the anesthetic propofol.

The injectable drug is one of the most widely used medicines for general anesthesia or sedation in operating rooms and intensive care units.

Doctors and the Food and Drug Administration have been concerned about a potential drug shortage since last fall.

Teva recalled some of the product in July 2009 after elevated levels of toxins were discovered at its Irvine, Calif., plant. The FDA said in a Dec. 11, 2009, warning letter released last month that it found "significant" manufacturing violations at the plant.

In a statement, the Israeli company said it is discontinuing its manufacture of propofol. "Our data supports that these products, when used and stored as directed, continue to be safe and effective and perform within the appropriate specification."

An FDA spokeswoman said propofol is still on its drug-shortage list. In November, the FDA took the unusual step of allowing APP Pharmaceuticals Inc., a subsidiary of Fresenius Kabi Pharmaceuticals Holding Inc., to import a similar product from one of its plants in Europe, after concerns about the shortage were raised by the American Society of Anesthesiologists.

The remaining U.S. propofol maker, Hospira Inc., has had two recalls, most recently on March 31. Hospira is not currently selling the product, a spokesman said. "We're implementing manufacturing changes to prevent the recurrence of a previous issue, and working with the FDA," he said.

THE AMERICAN SOCIETY OF ANESTHESIOLOGISTS

Anesthesiologists: Physicians providing the lifeline of modern medicine. Founded in 1905, the American Society of Anesthesiologists is an educational, research and scientific association with 46,000 members organized to raise and maintain the standards of the medical practice of anesthesiology and improve the care of the patient.

For more information on the field of anesthesiology, visit the American Society of Anesthesiologists Web site at www.asahq.org. For patient information, visit LifeLineToModernMedicine.com

###

Contact:

Jennifer Gremmels
j.gremmels@asahq.org
847-268-9128